Skip to main content

Miquel Vila Bover

I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR)

Institutions of which they are part

Head of group
Neurodegenerative Diseases
Vall Hebron Institut de Recerca
Miquel Vila Bover

Miquel Vila Bover

Miquel Vila Bover

Institutions of which they are part

Head of group
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR)

I have a degree in Medicine and Surgery from the University of Barcelona (1993) and a PhD in Neuroscience from the University of Paris 6 (1998). My doctoral work carried out in the laboratory of experimental neurology at the Salpetriere Hospital in Paris (1993-98) contributed to establishing the subthalamic nucleus as the main therapeutic target for the surgical treatment of Parkinson's disease with deep brain stimulation. From 1998 to 2005 I worked at the Movement Disorders Unit of Columbia University in New York (USA), initially as a postdoctoral researcher and from 2001 as an Assistant Professor of Neurology, focusing on the study of the mechanisms of neuronal death in Parkinson's disease to identify new therapeutic targets for this currently incurable neurodegenerative disorder.

In 2006 I moved to Barcelona as a Professor at ICREA (Catalan Institute of Research and Advanced Studies) to create and lead a new research group in neurodegenerative diseases at the Vall d'Hebron Research Institute (VHIR). Our group is now part of the Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) and the Aligning Science Across Parkinson's Collaborative Research Network (ASAP-CRN).

I am also an Associate Professor at the Autonomous University of Barcelona, Principal Investigator at CIBERNED, Coordinating Lead PI at ASAP-CRN and member of the Steering Committees of the World Parkinson Coalition and the Basic Science Special Interest Group of the International Parkinson and Movement Disorder Society.

Projects

Paper de la disfunció mitocondrial en la mort neuronal de la Malaltia de Parkinson.

IP: Miquel Vila Bover
Collaborators: -
Funding agency: Fundació Bancària "la Caixa"
Funding: 90000
Reference: BM06-153-0
Duration: 01/01/2007 - 31/12/2009

Molecular mechanisms of neurodegeneration: targeting programmed cell death as a new therapeutic strategy for Parkinson's disease

IP: -
Collaborators: Miquel Vila Bover
Funding agency: EUROPEAN COMMISSION
Funding:
Reference: MIRG-CT-2004-006505
Duration: 31/12/2005 - 30/09/2007

Muerte celular programada como diana terapéutica en la enfermedad de Parkinson

IP: Miquel Vila Bover
Collaborators: Laia Perez Lasarte
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 180400
Reference: RYC-2005-1561
Duration: 12/07/2006 - 31/10/2011

Ministerio de Ciencia

Targeting programmed cell death in Paarkinson's disease (Targeting PCD in PD)

IP: -
Collaborators: Miquel Vila Bover
Funding agency: EUROPEAN COMMISSION
Funding:
Reference: MEXT-CT-2005-024929
Duration: 01/12/2005 - 30/11/2009

Related news

The event focused on advances in disease-modifying therapies and on the value of alliances between patients and professionals to promote more participatory care and research.

This VHIR initiative promotes well-being, empathy and community participation in Barcelona neighbourhoods through an intergenerational model

PAIR is an intergenerational initiative with people affected by Parkinson's disease and adolescents.

Related professionals

Alba Gómez Garrido

Alba Gómez Garrido

Senior researcher
Physical Medicine and Rehabilitation
Read more
Carlos Molina Cateriano

Carlos Molina Cateriano

Head of group
Stroke research
Read more
Toni Soriano Colomé

Toni Soriano Colomé

Research technician
Cardiovascular Diseases
Read more
Maria Jose Gomez  Jurado

Maria Jose Gomez Jurado

Predoctoral researcher
General Surgery
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.